Full notification fileGeneral informationNotification NumberB/NL/11/006Member State to which the notification was sentNetherlandsDate of acknowledgement from the Member State Competent Authority05/10/2012Title of the ProjectVaccination of chickens with a combination vaccine against infectious laryngotracheitis (ILT) and Marek’s disease (MD)Proposed period of release:05/10/2012 to 31/12/2016Name of the Institute(s) or Company(ies)Intervet International bv, Boxmeer, The Netherlands;
3. Is the same GMO release planned elsewhere in the Community?Yes: Spain; Has the same GMO been notified elsewhere by the same notifier?NoGMO characterizationGMO is a:DNA VirusIdentity of the GMO:The Innovax-ILT vaccine contains the live cell-associated Herpesvirus of Turkey (HVT) strain HVT/ILT-138 in a cell-associated form. This is a vector vaccine: the HVT/ILT-138 virus strain was generated by inserting glycoprotein genes of Infectious Laryngotracheitis virus (ILTV) into the HVT strain FC-126 genome.
HVT belongs to the virus family Herpesviridae, subfamily Alphaherpesvirinae, genus "Marek's disease-like viruses" (also knows as the genus Mardivirus).Information relating to the recipient or parental organisms from wich the GMO is derived
European Commission administrative informationConsent given by the Member State Competent Authority:Not known
|HVT||Mardivirus||Meleagrid herpesvirus 1||-||FC-126||-|